Colorectal Neoplasm

Explore clinical trials studying Colorectal Neoplasm. Study availability and eligibility vary by location and protocol.

37 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Colorectal Neoplasm trial results

Completed

Study Using CP-751,871 In Patients With Stage IV Colorectal Cancer That Has Not Responded To Previous Anti-Cancer Treatments

NCT00560560

Conditions: Colonic Diseases, Colorectal Neoplasm, Colorectal Neoplasms, +9 more
Locations: Pfizer Investigational Site San Francisco, California, United States

Pfizer Investigational Site Dallas, Texas, United States

Pfizer Investigational Site Elche, Alicante, Spain

Pfizer Investigational Site Barcelona, Spain

View Trial Details

Completed

Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal Cancer

NCT00677144

Conditions: Colonic Diseases, Colorectal Neoplasm, Colorectal Neoplasms, +9 more
Locations: Hallym University Medical Center Anyang, South Korea

View Trial Details

Completed

The Usefulness of I-scan in Screening Colonoscopy

NCT01417611

Conditions: Colonic Diseases, Colorectal Neoplasm, Colorectal Neoplasms, +9 more
Locations: Healthcare Center, Digestive Disease Center, Konkuk University Medical Center Seoul, South Korea

View Trial Details

Completed

Comparing Hepatic Intra-arterial Injection of Yttrium-90 Microspheres Versus Fluorouracil (5FU) in Colorectal Cancer Metastatic to the Liver Only

NCT00199173

Conditions: Colonic Diseases, Colorectal Neoplasm, Colorectal Neoplasms, +10 more
Locations: Jules Bordet Institute Brussels, Belgium

View Trial Details

Completed

Phase II Study of the Role of Anti-CEA Antibody Immunoscintigraphy & Positron Emission Tomography in the Localization of Recurrent Colorectal Carcinoma in Patients With Rising Serum CEA Levels in the Absence of Imageable Disease by Conventional Modalities

NCT00001568

Conditions: Colonic Diseases, Colorectal Neoplasm, Colorectal Neoplasms, +9 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver

NCT00001576

Conditions: Body Temperature Changes, Colonic Diseases, Colorectal Neoplasm, +21 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and Carriers

NCT00001693

Conditions: Colonic Diseases, Colorectal Neoplasm, Colorectal Neoplasms, +10 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Colorectal Neoplasm

Colorectal Neoplasm trial results

Study Using CP-751,871 In Patients With Stage IV Colorectal Cancer That Has Not Responded To Previous Anti-Cancer Treatments

Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal Cancer

The Usefulness of I-scan in Screening Colonoscopy

Comparing Hepatic Intra-arterial Injection of Yttrium-90 Microspheres Versus Fluorouracil (5FU) in Colorectal Cancer Metastatic to the Liver Only

Phase II Study of the Role of Anti-CEA Antibody Immunoscintigraphy & Positron Emission Tomography in the Localization of Recurrent Colorectal Carcinoma in Patients With Rising Serum CEA Levels in the Absence of Imageable Disease by Conventional Modalities

A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver

Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and Carriers

Related conditions